数字分装定制面板用于氨曲南-阿维巴坦药敏试验的验证
该研究依据CLSI指南,采用CDC内部制备的冷冻微量肉汤稀释(BMD)面板,对氨曲南-阿维巴坦进行药敏试验的内部验证,并评估HP D300e数字分装机制备面板的性能。结果表明,数字分装面板与常规制备的冷冻参考BMD面板对包括氨曲南-阿维巴坦在内的多种药物性能相当,且数字分装易于使用并能制备复杂药物面板。
要点
- 氨曲南-阿维巴坦对产金属β-内酰胺酶的碳青霉烯酶肠杆菌目细菌有活性。
- 目前氨曲南-阿维巴坦药敏试验无商业产品,临床缺乏实验室指导。
- 数字分装面板性能与常规冷冻参考BMD面板等效,便于实验室开展药敏试验。
核心结论
- 数字分装定制面板与常规制备的冷冻参考BMD面板对氨曲南-阿维巴坦等药物的性能特征相当。
- HP D300e数字分装机易于使用,能够制备复杂药物面板。
研究设计与样本
- 依据CLSI指南进行内部验证,使用CDC内部制备的定制冷冻参考BMD面板。
- 评估HP D300e数字分装机制备面板的新方法。
主要发现
- 数字分装面板与常规冷冻参考BMD面板对多种药物(包括氨曲南-阿维巴坦)的性能特征等效。
- HP D300e数字分装机易于使用且能制备复杂药物面板。
临床怎么用
- 有助于其他临床和公共卫生实验室开展氨曲南-阿维巴坦药敏试验。
- 为临床考虑使用氨曲南-阿维巴坦治疗严重碳青霉烯酶肠杆菌目细菌感染提供实验室依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Aztreonam-avibactam is a combination antimicrobial agent with activity against carbapenemase-producing Enterobacteriaceae (CPE) with metallo-β-lactamases (MβLs). Although aztreonam-avibactam is not yet approved by the U.S. Food and Drug Administration (FDA), clinicians can administer this combination by using two FDA-approved drugs: aztreonam and ceftazidime-avibactam. This combination of drugs is recommended by multiple experts for treatment of serious infections caused by MβL-producing CPE. At present, in vitro antimicrobial susceptibility testing (AST) of aztreonam-avibactam is not commercially available; thus, most clinicians receive no laboratory-based guidance that can support consideration of aztreonam-avibactam for serious CPE infections. Here, we report our internal validation for aztreonam-avibactam AST by reference broth microdilution (BMD) according to Clinical and Laboratory Standards Institute (CLSI) guidelines. The validation was performed using custom frozen reference BMD panels prepared in-house at the Centers for Disease Control and Prevention (CDC). In addition, we took this opportunity to evaluate a new panel-making method using a digital dispenser, the Hewlett Packard (HP) D300e. Our studies demonstrate that the performance characteristics of digitally dispensed panels were equivalent to those of conventionally prepared frozen reference BMD panels for a number of drugs, including aztreonam-avibactam. We found the HP D300e digital dispenser to be easy to use and to provide the capacity to prepare complex drug panels. Our findings will help other clinical and public health laboratories implement susceptibility testing for aztreonam-avibactam.
引用
- Ransom E, Bhatnagar A, Patel JB, et al. Validation of Aztreonam-Avibactam Susceptibility Testing Using Digitally Dispensed Custom Panels. J Clin Microbiol. 2020. PMID: 32051259. doi:10.1128/JCM.01944-19
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。